CBAI) slipped 6.67% to $0.0028 on a traded volume of 1.06 million shares. So far this year, the stock is down over 44%. The 52-week range for the stock is $0.0 and $0.04. CBAI is primarily an umbilical cord blood stem cell preservation company, with a particular focus on the acquisition of customers in need of family based products and services.
http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=20696
http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=20696
No comments:
Post a Comment